NEW YORK, June 27, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
India Biopharmaceuticals market
This is a detailed report on the biopharmaceuticals market in
India. India has emerged as one of the most potential biotech
destinations of the world. In fact, biotechnology is the new IT of
India. There is a clear consensus among the people in that
biotechnology has the potential to create a revolution in the field
of agriculture, industrial and service production. This enthusiasm
and drive has resulted in the Indian biotech market reaching INR
14,199 crore in 2009-10.
By segment, biopharmaceuticals dominate the biotechnology
market. India is the home to more than 130 biopharmaceutical
companies, many of which are fully integrated. These companies
account for around 70% of the total biotech market.
Biopharmaceutical sector has shown dramatic growth over the past
few years, with the overall market reaching Rs. 6543 crore in
2008-09, thanks to a fast-growing economy, large population and
intellectual property-supportive regime. And as domestic demand for
better healthcare increases and international opportunities for
biologics rise, India will continue to expand its presence on the
world biopharmaceutical stage.
Executive Summary
Industry Overview
Science of Biopharmaceuticals
Pharmaceuticals, Biotechnology and Biopharmaceuticals
Biopharmaceuticals
P
‘/>”/>
